TMPRSS2 and COVID-19: Furthermore, our results provide mechanistic evidence suggesting that genistein may be utilised as a preventive measure against the inflammation-induced rise in SGLT1 and TMPRSS2, potentially aiding in lowering postprandial glycaemic response and COVID-19 pathophysiology.